Works matching IS 02704137 AND DT 2022 AND VI 82 AND IP 2

Results: 15

Comparison of prostate cancer detection rates in patients undergoing MRI/TRUS fusion prostate biopsy with two different software‐based systems.

Published in:

Prostate, 2022, v. 82, n. 2, p. 227, doi. 10.1002/pros.24264

By:

Hanske, Julian;
Risse, Yannic;
Roghmann, Florian;
Pucheril, Daniel;
Berg, Sebastian;
Tully, Karl H.;
von Landenberg, Nicolas;
Wald, Jan;
Noldus, Joachim;
Brock, Marko

Publication type:

Article

The prognostic nutritional index predicts the biochemical recurrence of patients treated with robot‐assisted laparoscopic radical prostatectomy.

Published in:

Prostate, 2022, v. 82, n. 2, p. 221, doi. 10.1002/pros.24263

By:

Li, Nichujie;
Song, Wei‐Jie;
Gao, Jun;
Xu, Zhi‐Peng;
Long, Zhi;
Liu, Jian‐Ye;
He, Le‐Ye

Publication type:

Article

Effects of the 2012 and 2018 US preventive services task force prostate cancer screening guidelines on pathologic outcomes after prostatectomy.

Published in:

Prostate, 2022, v. 82, n. 2, p. 216, doi. 10.1002/pros.24261

By:

Plambeck, Benjamin D.;
Wang, Luke L.;
Mcgirr, Samantha;
Jiang, Jinfeng;
Van Leeuwen, Bryant J.;
Lagrange, Chad A.;
Boyle, Shawna L.

Publication type:

Article

Phase I clinical trial of HC‐1119 soft capsule in Chinese healthy adult male subjects: Pharmacokinetics and safety of single‐dose proportionality and effects of food.

Published in:

Prostate, 2022, v. 82, n. 2, p. 276, doi. 10.1002/pros.24271

By:

Ma, Haiping;
Xu, Weidong;
Ni, Jin;
Zhao, Naping;
Tang, Shouyan;
Li, Song;
Cai, Tingting;
Xiu, Jianping;
Kang, Xin;
Gao, Shen;
Zhang, Li;
Zhou, Tie

Publication type:

Article

Overall and progression‐free survival of Afro‐Caribbean men with metastatic castration‐resistant prostate cancer (mCRPC).

Published in:

Prostate, 2022, v. 82, n. 2, p. 269, doi. 10.1002/pros.24270

By:

Vestris, Pierre‐Gilles;
Gourtaud, Gilles;
Senechal, Cédric;
Sadreux, Yvanne;
Roux, Virginie;
Blanchet, Pascal;
Brureau, Laurent

Publication type:

Article

Concordance of biopsy and pathologic ISUP grading in salvage radical prostatectomy patients for recurrent prostate cancer.

Published in:

Prostate, 2022, v. 82, n. 2, p. 254, doi. 10.1002/pros.24268

By:

Preisser, Felix;
Würnschimmel, Christoph;
Pose, Randi M.;
Heinze, Alexander;
Steuber, Thomas;
Michl, Uwe;
Salomon, Georg;
Mandel, Philipp;
Graefen, Markus;
Tilki, Derya

Publication type:

Article

Clinical and genomic features of SPOP‐mutant prostate cancer.

Published in:

Prostate, 2022, v. 82, n. 2, p. 260, doi. 10.1002/pros.24269

By:

Nakazawa, Mari;
Fang, Mike;
H. Marshall, Catherine;
Lotan, Tamara L.;
Isaacsson Velho, Pedro;
Antonarakis, Emmanuel S.

Publication type:

Article

Long‐term first‐in‐man Phase I/II study of an adjuvant dendritic cell vaccine in patients with high‐risk prostate cancer after radical prostatectomy.

Published in:

Prostate, 2022, v. 82, n. 2, p. 245, doi. 10.1002/pros.24267

By:

Tryggestad, Anne M. A.;
Axcrona, Karol;
Axcrona, Ulrika;
Bigalke, Iris;
Brennhovd, Bjørn;
Inderberg, Else M.;
Hønnåshagen, Turid K.;
Skoge, Lisbeth J.;
Solum, Guri;
Sæbøe‐Larssen, Stein;
Josefsen, Dag;
Olaussen, Richard W.;
Aamdal, Steinar;
Skotheim, Rolf I.;
Myklebust, Tor Å.;
Schendel, Dolores J.;
Lilleby, Wolfgang;
Dueland, Svein;
Kvalheim, Gunnar

Publication type:

Article

Optimization of clinical risk‐factor interpretation and radiological findings with machine learning for PIRADS category 3 patients.

Published in:

Prostate, 2022, v. 82, n. 2, p. 235, doi. 10.1002/pros.24266

By:

Aussavavirojekul, Pubordee;
Hoonlor, Apirak;
Srinualnad, Sittiporn

Publication type:

Article

Impact of prostate biopsy secondary pathology review on radiotherapy management.

Published in:

Prostate, 2022, v. 82, n. 2, p. 210, doi. 10.1002/pros.24260

By:

Siedow, Michael;
Eisner, Mariah;
Yaney, Alexander;
Washington, Iman;
Zynger, Debra;
Martin, Douglas;
Mo, Xiaokui;
Diconstanzo, Dominic;
Diaz, Dayssy Alexandra

Publication type:

Article

Prostate cancer research in the 21st century; report from the 2021 Coffey‐Holden prostate cancer academy meeting.

Published in:

Prostate, 2022, v. 82, n. 2, p. 169, doi. 10.1002/pros.24262

By:

Miyahira, Andrea K.;
Zarif, Jelani C.;
Coombs, Catherine C.;
Flavell, Robert R.;
Russo, Joshua W.;
Zaidi, Samir;
Zhao, Di;
Zhao, Shuang G.;
Pienta, Kenneth J.;
Soule, Howard R.

Publication type:

Article

Long‐term outcomes of Holmium laser enucleation of prostate and predictive model for symptom recurrence.

Published in:

Prostate, 2022, v. 82, n. 2, p. 203, doi. 10.1002/pros.24259

By:

Droghetti, Matteo;
Porreca, Angelo;
Bianchi, Lorenzo;
Piazza, Pietro;
Giampaoli, Marco;
Casablanca, Carlo;
D'Agostino, Daniele;
Cochetti, Giovanni;
Romagnoli, Daniele;
Schiavina, Riccardo;
Brunocilla, Eugenio

Publication type:

Article

Spatial and temporal patterns of prostate cancer burden and their association with Socio‐Demographic Index in Asia, 1990–2019.

Published in:

Prostate, 2022, v. 82, n. 2, p. 193, doi. 10.1002/pros.24258

By:

Luo, Li‐Sha;
Jiang, Jun‐Feng;
Luan, Hang‐Hang;
Zi, Hao;
Zhu, Cong;
Li, Bing‐Hui;
Zeng, Xian‐Tao

Publication type:

Article

Androgen receptor negatively regulates mitotic checkpoint signaling to induce docetaxel resistance in castration‐resistant prostate cancer.

Published in:

Prostate, 2022, v. 82, n. 2, p. 182, doi. 10.1002/pros.24257

By:

Pilling, Amanda;
Kim, Sahn‐Ho;
Hwang, Clara

Publication type:

Article

Issue Information.

Published in:: Prostate, 2022, v. 82, n. 2, p. 167, doi. 10.1002/pros.24152
Publication type:: Article